• 740 Y-P for Reproducible PI3K/AKT Assays

  2026-09-08

  This scenario-based guide explains how 740 Y-P (SKU B5246) can support controlled PI3K/AKT pathway activation in cell viability, neuronal survival, cancer, and vesicular trafficking experiments. It covers assay design, stock preparation, interpretation, and practical vendor-selection criteria using product specifications and published pathway evidence.

• Patient-Derived Spheroids for Prostate Cancer Research

  2026-09-08

  The reference study established viable three-dimensional spheroid cultures from organ-confined prostate cancer specimens obtained during radical prostatectomy. These cultures preserved clinically relevant epithelial and androgen receptor markers, supported cryopreservation and drug testing, and revealed stronger viability loss with bicalutamide and enzalutamide than with docetaxel or abiraterone under the reported conditions.

• 7-Ethyl-10-hydroxycamptothecin: Assay Logic

  2026-09-07

  7-Ethyl-10-hydroxycamptothecin (SN-38) is more than a DNA topoisomerase I inhibitor. This article presents an evidence-based assay framework for separating topoisomerase-mediated DNA damage, FUBP1/FUSE disruption, cell-cycle arrest, and apoptosis in advanced colon cancer research.

• URB597 (KDS-4103) for FAAH Research

  2026-09-07

  URB597 (KDS-4103) provides a selective way to raise anandamide and test FAAH-dependent endocannabinoid signaling without directly activating cannabinoid receptors. This workflow-focused guide connects brain-membrane assays, intact-neuron experiments, and pain-related behavioral models with practical controls and troubleshooting strategies.

• Crystal Violet Staining Solution: Readout Logic

  2026-09-05

  Crystal Violet Staining Solution is more than a nuclear staining dye: its signal reflects how cells or biofilms remain attached to a surface. This guide connects assay chemistry, orthogonal validation, and practical interpretation for proliferation, migration, invasion, colony formation, and biofilm studies.

• NF 340: A Rigorous P2Y11 Signaling Study Guide

  2026-09-04

  NF 340 is a selective P2Y11 antagonist for dissecting purinergic GPCR signaling in cancer, immunology research, and inflammation studies. This evidence-aware guide explains what the QPRT breast cancer study establishes, how to design stronger assays, and where receptor-level conclusions remain limited.

• Tyrothricin Workflows for Membrane Research

  2026-09-04

  Tyrothricin is a practical peptide antibiotic mixture for connecting growth inhibition with direct membrane-injury measurements. This guide presents fresh-solution handling, quantitative bacterial and fungal assay workflows, cross-domain interpretation, and troubleshooting strategies for reproducible antimicrobial research.

• TPPU: A Soluble Epoxide Hydrolase Inhibitor

  2026-09-03

  TPPU is a nanomolar soluble epoxide hydrolase inhibitor for dissecting fatty acid epoxide signaling in inflammatory pain, osteoclast, and liver–bone experiments. Its high potency, human and mouse sEH activity, and compatibility with pharmacological and lipidomic workflows make it useful for separating target engagement from downstream Nrf2 and cytokine effects.

• Dimethyloxalylglycine (DMOG) Protocol Guide

  2026-09-03

  Dimethyloxalylglycine (DMOG), SKU A4506, provides a practical way to investigate hypoxia-inducible factor stabilization under normoxic cell-culture conditions and in selected inflammation workflows. It is a research reagent only; the available dossier does not establish diagnostic, therapeutic, or clinical use, and no directly matched paper evidence is available for this product entry.

• AG-120 (Ivosidenib): A Metabolic Assay Framework

  2026-09-02

  AG-120 (Ivosidenib) is a selective mutant IDH1 inhibitor whose 2-hydroxyglutarate reduction can be connected to differentiation and metabolic-state readouts. This guide presents a resistance-aware assay framework informed by recent CD44–NADPH biology rather than repeating conventional compound optimization advice.

• 3-Hydroxybutyrate (BHBA) in Stroke Research

  2026-09-02

  Use 3-hydroxybutyrate (BHBA) to model ketosis while connecting energy metabolism, ferroptosis, mitochondrial integrity, and chromatin regulation in neuronal assays. This workflow translates a stroke neuroprotection study into practical dose-finding, endpoint selection, and troubleshooting strategies.

• Streptozotocin for Diabetes and Neuropathy Models

  2026-09-01

  Learn how STZ converts GLUT2-mediated β-cell targeting into a controlled hyperglycemia model, then connect metabolic injury to pain and neuroinflammation assays. This workflow combines dose and solvent logic with findings on TBK1-driven microglial pyroptosis to support more informative diabetes research.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-01

  The reference study combines patient data, mouse sepsis models, and human microvascular endothelial cell experiments to position moesin as both a severity-associated biomarker and a contributor to endothelial hyperpermeability. Its results connect circulating moesin with SOFA, procalcitonin, lung injury, and Rock1/MLC and NF-κB signaling, while also defining important limits for clinical translation.

• Arachidonic Acid as a Dietary Vaccine Adjuvant

  2026-08-31

  The reference study shows that dietary arachidonic acid can accelerate and strengthen rabies vaccine-induced humoral immunity in mice and human volunteers. Its key contribution is a mechanistic link between lymph-node lipid metabolism, prostaglandin I2 signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.

• Camostat Mesilate: Assay Workflows and Optimization

  2026-08-31

  Camostat Mesilate is a practical trypsin-like protease inhibitor for dissecting ENaC-linked epithelial signaling and the plasmin–TGF-β–fibrosis axis. This guide translates its product profile into dose-response, pathway-validation, and troubleshooting workflows while distinguishing protease biology from structure-guided antiviral PPI inhibition.

8546 records 1/570 page Next 12345 下5页 Last page